HCM Acquisition Corp (NASDAQ:HCMA – Get Rating) saw a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 1,600 shares, a growth of 128.6% from the October 15th total of 700 shares. Based on an average daily trading volume, of 33,600 shares, the short-interest ratio is presently 0.0 days.
HCM Acquisition Stock Up 0.4 %
Shares of NASDAQ HCMA traded up $0.04 during trading on Friday, hitting $10.21. 500,000 shares of the company traded hands, compared to its average volume of 3,614. The company has a 50-day moving average price of $10.11 and a 200-day moving average price of $10.04. HCM Acquisition has a 1 year low of $9.87 and a 1 year high of $10.55.
Get
HCM Acquisition alerts:
Institutional Trading of HCM Acquisition
A number of institutional investors have recently added to or reduced their stakes in HCMA. Highbridge Capital Management LLC purchased a new stake in HCM Acquisition during the 1st quarter worth $12,121,000. MMCAP International Inc. SPC purchased a new stake in HCM Acquisition during the 1st quarter worth $9,970,000. Glazer Capital LLC purchased a new position in HCM Acquisition in the 1st quarter valued at about $9,860,000. Polar Asset Management Partners Inc. purchased a new position in HCM Acquisition in the 1st quarter valued at about $7,976,000. Finally, Taconic Capital Advisors LP purchased a new position in HCM Acquisition in the 1st quarter valued at about $7,478,000. 64.88% of the stock is owned by hedge funds and other institutional investors.
HCM Acquisition Company Profile
(Get Rating)
HCM Acquisition Corp does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2021 and is based in Stamford, Connecticut.
See Also
- Get a free copy of the StockNews.com research report on HCM Acquisition (HCMA)
- MarketBeat: Week in Review 11/7 – 11/11
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn't Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don't Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
Receive News & Ratings for HCM Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCM Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
